Neuronostics Limited
11123728
Healthy
- Loss before tax (-10)
Details
Compliance
Last accounts
31/12/2024
total exemption full
Next accounts due
30/09/2026
Confirmation statement
Last: 08/12/2025
Due 22/12/2026
Industry
Officers
director · Since 30/03/2021
DIRECTOR
BRITISH · ENGLAND · Age 73
Also on 4 other boards
director · Since 24/07/2025
DIRECTOR
AMERICAN · UNITED STATES · Age 58
Also on 1 other board
Persons with Significant Control
Former PSCs
Mr Martin Brown
Ceased 18/06/2018
Mr Wessel Woldman
Ceased 30/04/2021
Professor John Terry
Ceased 03/04/2023
CompanyRankvs 35800+ SIC 72190 peers49
Show leaderboard
How is this score calculated?
Net worth compared to all companies in the same SIC code with published accounts. Top quartile earns the full 25 points.
Workforce size relative to sector peers from the most recent accounts. A larger team generally signals commercial scale.
Current assets ÷ current liabilities. A ratio above 2× earns full marks; between 1–2× scores partially; below 0.5× scores minimal points.
One point per year of operation since incorporation, capped at 15. Older companies have a proven track record.
Full 15 points when both annual accounts and confirmation statement are filed on time. Points are deducted for each overdue filing.
Maximum score is 100. Deductions apply for insolvency history, outstanding charges, going concern doubt, or disqualified officers.
Key FinancialsYear ending 31/12/2024
Turnover
£104k
Annual revenue
Net Worth
£168
Balance sheet strength
Cash
—
Cash in the bank
Profit Before Tax
-£504k
Bottom line earnings
Net Current Assets
—
Working capital
Current Assets
—
Current Liabilities
£96k
Fixed Assets
£12k
Debtors
£387k
Admin Expenses
£81k
Operating Profit
-£510k
Profit After Tax
-£454k
Balance Sheet
EstimatesDerived
| Year | Current Ratio | Implied Profit |
|---|---|---|
| 2023 | 10.87 | +£685k |
| 2022 | 1.41 | -£359k |
| 2021 | 16.06 | +£506k |
| 2020 | 0.71 | +£15k |
| 2019 | 0.51 | -£55k |
| 2018 | 6.06 | — |
Derived from filed accounts. Not audited figures.